ApprovalTrail

Approval · Notice of Compliance 6098 · 2002

COMPONENT E-S IMPLANTS WITH TYLAN: Notice of Compliance 6098

Issued May 21, 2002

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
6098
Date
May 21, 2002
Product type
Veterinary
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Growth promotant and antibacterial

Products in this notice

BrandDINStatus today
COMPONENT E-S IMPLANTS WITH TYLAN02245743Marketed

Medicinal ingredients